BioWorld MedTech

June 3, 2014

View Archived Issues

J&J emphasizing Chinese market in push to drive future company growth

Biomed Israel 2014: Biomed Israel conference celebrates innovation in an interactive environment

Inside the Beltway: House prods FDA over artificial pancreas in FY 2015 budget bill

Financings: Proteus Digital raises $120 million from new investors in funding round

M&A: St. Jude Medical completes acquisition of CardioMEMS

Agreements/contracts: Valley Health selects Medline as its distributor for medical/surgical supplies

World in Review: Medtronic launches Advisa and SureScan single chamber pacemakers

Hit Bits: MicroStrategy launches mobile app based on CMS, CDC, and census data

Products

People in Places

MDD's Cardiology Extra

Collaboration expected to PROMPT accelerated hereditary cancer research

There's still no cure for cancer but advances in gene sequencing technology have made it more possible to identify people with particularly high risk of developing cancer. Read More

MDD Perspectives: Stryker S&N acquisition rumors bolster recent orthopedic space

Today's news in brief

BioWorld

BioWorld briefs for June 15, 2026.

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...

EHA 2026: With new lenses, a changing view on pediatric cancers

BioWorld

In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...

Microscopic image of chronic myeloid leukemia

Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

BioWorld

Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...

Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs

BioWorld Science

Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...